Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+.
Chan
J K
JK
Tsang
W Y
WY
Ng
C S
CS
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018801:CD2 Antigens / Q000032:analysis; D017252:CD3 Complex / Q000032:analysis*; D019002:CD56 Antigen / Q000032:analysis; D005188:False Negative Reactions; D005629:Frozen Sections; D006801:Humans; D016130:Immunophenotyping / Q000379:methods*; D007694:Killer Cells, Natural / Q000737:chemistry* / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000473:pathology*; D009669:Nose Neoplasms / Q000276:immunology / Q000473:pathology*; D016612:Paraffin Embedding; D011817:Rabbits; D016176:T-Lymphocyte Subsets / Q000737:chemistry* / Q000473:pathology
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018801:CD2 Antigens; D017252:CD3 Complex; D019002:CD56 Antigen